Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
106,692,854
-
Share change
-
-3,516,152
-
Total reported value
-
$5,685,431,048
-
Put/Call ratio
-
14%
-
Price per share
-
$53.29
-
Number of holders
-
405
-
Value change
-
-$155,605,070
-
Number of buys
-
162
-
Number of sells
-
225
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q4 2023
As of 31 Dec 2023,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
405 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
106,692,854 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, Bank of New York Mellon Corp, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Camber Capital Management LP, MILLENNIUM MANAGEMENT LLC, and JPMORGAN CHASE & CO.
This page lists
405
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.